SavedAdd your journal

Journals / Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2002 / Cilt: 42 - Sayı: 4

Comparison of the effect of calcium acetate and calcium carbonate on parathormone level in patients under heamodialysis with chronic renal failure and hyperphosphatemia

Kronik renal yetersizlikli hemodialize giren hiperfosfatemili hastalarda kalsiyum asetat ve kalsiyum karbonatın parathormon üzerine olan etkilerinin karşılaştırılması

Müzeyyen KARASAKAL
Neslihan AYDIN
Bedri DURMUŞ
Ömer Atalay YÜREKLİ
Ramazan Yunus GÜL
Arslan DAĞAR
Pages
12–17
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Finally, there was significant increasing in calcium level (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The study was designed to compare the effect of equal doses of calcium acetat and calcium carbonate on calcium, phosphore, alcalane phosphatase and parathyroid hormone level in patients under heamodialisis with chronic renal failure. 12 female and 18 male patients whose ages were between 20 to 83 years old were included in the study.
📊
Key Findings & Data:First group was given calcium acetate 6 gram daily and second group was given calcium carbonat 3.75 gram daily.
💡
Conclusion & Impact:Finally, there was significant increasing in calcium level (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The study was designed to compare the effect of equal doses of calcium acetat and calcium carbonate on calcium, phosphore, alcalane phosphatase and parathyroid hormone level in patients under heamodialisis with chronic renal failure. 12 female and 18 male patients whose ages were between 20 to 83 years old were included in the study. Patients were divided in two groups. First group was given calcium acetate 6 gram daily and second group was given calcium carbonat 3.75 gram daily. Serum Ca, P, ALP and PTH level have been checked for 6 weeks. Finally, there was significant increasing in calcium level (p

Özet

Kronik Renal Yetersizlikli hemodializ hastalarında kalsiyum asetat ve kalsiyum karbonatın eşit mollü dozlarının serum Ca, P, ALP, PTH düzeylerine etkilerini karşılaştırmak amacıyla yaptığımız bu çalışmaya yaşları 20-83 arasında değjşen 12 kadın, 18 erkek olmak üzere toplam 30 hasta alındı. Hastalar iki gruba ayrılarak ilk gruba (n:30) kalsiyum asetat günde 3 kez 2 gr., ikinci gruba (n:30) kalsiyum karbonat günde 3 kez 1.25 gr dozlarında verildi. 6 hafta süre ile hastaların serum Ca, P, ALP, PTH düzeyleri izlendi. Bu süre sonunda kalsiyum asetat alan hastalarda kalsiyum seviyesinde istatistiksel olarak çok ileri düzeyde anlamlı yükselme(p

🔖

Cite This Article

KARASAKAL, M., AYDIN, N., DURMUŞ, B., YÜREKLİ, Ö. A., GÜL, R. Y., DAĞAR, A. (2022). Comparison of the effect of calcium acetate and calcium carbonate on parathormone level in patients under heamodialysis with chronic renal failure and hyperphosphatemia. Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 42 - Sayı: 4, 12–17. https://ajindex.com/articles/535760

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Bernard Hory ( Turnan B. Brüecke. The parathytoid bone axis in uremia: New insights into old questions. Curr Op In Nephr(Hypert1997; 6:pp:40-48
  2. Clinical Dialysis. Nissenson AR, Fine RN, Gentile DE: Prentice-Hall International Inc., 1990
  3. Schreiner GE. Uremia. Chapter 38, Textbook of Nephrology, second edition, William ( Wilkins; Baltimore USA,1989; s.540-547
  4. Delmez, JA and Slatopolsky, E. Hyperphosphatemia:Its consequences and treatment in patients with chronic renal insuffeciency. Am J Kidney Dis 1992; 19:303
  5. Llach, F. And Missry, SC. On the mechanism of secondary hyperparathyroidism in moderate renal insuffeciecy.J Clin Endocrinol Metab 1985; 61:601
  6. Sawyer N, Et al. High dose calcium carbonate with step-wise reduction in dialisate calcium concetration. Effective phosphate control and aluminum avoidance in dialyse patients. Nephrol Dial Transplant 1989; 4(2):105
  7. Boyce BF, Fell GS, Elder H, et al. Hypercalcemic osteomalacia due to aluminium toxicity. Lancet 1982; 2:1009-1013
  8. Delmez JA, et al. Calcium acetate as phosphorus binder in haemodialysis patients. J Am Soc Nephrol 1992;3:96
  9. Couttenye MM, etal. Predictive value of low serum bone alkaline phosphatase (BAP) in the diagnosis of dynamic bone disease (ABO). J Am Soc Nephrol 1992 (Abstract) 3(3):672.